Varex Imaging [VREX] vs Abbott Laboratories [ABT] Detailed Stock Comparison
Varex Imaging
NASDAQ
Loading...
Abbott Laboratories
NYSE
Loading...
TLDR: Quick Comparison Summary
Based on 20 vital metrics comparison: Varex Imaging wins in 6 metrics, Abbott Laboratories wins in 12 metrics, with 0 ties. Abbott Laboratories appears stronger overall.
View Metrics Details
Vital Metrics Comparison
| Metric | Varex Imaging | Abbott Laboratories | Better |
|---|---|---|---|
| P/E Ratio (TTM) | 19.08 | 16.64 | Abbott Laboratories |
| Price-to-Book Ratio | 1.05 | 4.57 | Varex Imaging |
| Debt-to-Equity Ratio | 84.54 | 26.50 | Abbott Laboratories |
| PEG Ratio | 0.00 | 0.45 | Varex Imaging |
| EV/EBITDA | -78.49 | 20.72 | Varex Imaging |
| Profit Margin (TTM) | -16.13% | 32.43% | Abbott Laboratories |
| Operating Margin (TTM) | -39.75% | 19.73% | Abbott Laboratories |
| EBITDA Margin (TTM) | N/A | 19.73% | N/A |
| Return on Equity | -24.79% | 30.93% | Abbott Laboratories |
| Return on Assets (TTM) | -1.96% | 6.62% | Abbott Laboratories |
| Free Cash Flow (TTM) | $20.40M | $6.35B | Abbott Laboratories |
| Dividend Yield | N/A | 1.28% | N/A |
| 1-Year Return | -7.45% | 17.12% | Abbott Laboratories |
| Price-to-Sales Ratio (TTM) | 0.58 | 5.36 | Varex Imaging |
| Enterprise Value | $737.83M | $237.34B | Abbott Laboratories |
| EV/Revenue Ratio | 0.90 | 5.51 | Varex Imaging |
| Gross Profit Margin (TTM) | 33.25% | 56.44% | Abbott Laboratories |
| Revenue per Share (TTM) | $20 | $25 | Abbott Laboratories |
| Earnings per Share (Diluted) | $-3.23 | $7.97 | Abbott Laboratories |
| Beta (Stock Volatility) | 0.68 | 0.71 | Varex Imaging |
Performance
Key Stats
Valuation
Financials
Short Interest
Dividends
Varex Imaging vs Abbott Laboratories Stock Performance Analysis
Loading Price Chart...
Performance Comparison
Short-term Returns
| Stock | 1D | 1W | 1M | 3M | 6M | YTD |
|---|---|---|---|---|---|---|
| Varex Imaging | 0.70% | -0.60% | 47.89% | 46.57% | -10.19% | -19.85% |
| Abbott Laboratories | 0.98% | 0.05% | 3.63% | -0.14% | -3.88% | 16.94% |
Long-term Returns
| Stock | 1Y | 3Y | 5Y | 10Y | 15Y | 20Y |
|---|---|---|---|---|---|---|
| Varex Imaging | -7.45% | -46.23% | 6.55% | -54.55% | -54.55% | -54.55% |
| Abbott Laboratories | 17.12% | 29.42% | 27.36% | 208.01% | 444.80% | 516.16% |
Performance & Financial Health Analysis: Varex Imaging vs Abbott Laboratories
| Metric | VREX | ABT |
|---|---|---|
| Market Information | ||
| Market Cap | $529.41M | $243.19B |
| Market Cap Category | Small cap | Mega cap |
| 10 Day Avg. Volume | 367,070 | 4,507,400 |
| 90 Day Avg. Volume | 477,890 | 5,725,327 |
| Last Close | $11.55 | $132.66 |
| 52 Week Range | $6.76 - $16.93 | $110.86 - $141.23 |
| % from 52W High | -31.78% | -6.07% |
| All-Time High | $43.76 (Jan 29, 2018) | $142.60 (Dec 27, 2021) |
| % from All-Time High | -73.61% | -6.97% |
| Growth Metrics | ||
| Quarterly Revenue Growth | -0.03% | 0.07% |
| Quarterly Earnings Growth | N/A | 0.37% |
| Financial Health | ||
| Profit Margin (TTM) | -0.16% | 0.32% |
| Operating Margin (TTM) | -0.40% | 0.20% |
| Return on Equity (TTM) | -0.25% | 0.31% |
| Debt to Equity (MRQ) | 84.54 | 26.50 |
| Cash & Liquidity | ||
| Book Value per Share (MRQ) | $10.97 | $29.05 |
| Cash per Share (MRQ) | $3.68 | $4.18 |
| Operating Cash Flow (TTM) | $59.70M | $9.04B |
| Levered Free Cash Flow (TTM) | $-4,112,500 | $5.92B |
| Dividends | ||
| Last 12-Month Dividend Yield | N/A | 1.28% |
| Last 12-Month Dividend | N/A | $1.69 |
Valuation & Enterprise Metrics Analysis: Varex Imaging vs Abbott Laboratories
| Metric | VREX | ABT |
|---|---|---|
| Price Ratios | ||
| P/E Ratio (TTM) | 19.08 | 16.64 |
| Forward P/E | 17.24 | 25.71 |
| PEG Ratio | 0.00 | 0.45 |
| Price to Sales (TTM) | 0.58 | 5.36 |
| Price to Book (MRQ) | 1.05 | 4.57 |
| Market Capitalization | ||
| Market Capitalization | $529.41M | $243.19B |
| Enterprise Value | $737.83M | $237.34B |
| Enterprise Value Metrics | ||
| Enterprise to Revenue | 0.90 | 5.51 |
| Enterprise to EBITDA | -78.49 | 20.72 |
| Risk & Other Metrics | ||
| Beta | 0.68 | 0.71 |
| Book Value per Share (MRQ) | $10.97 | $29.05 |
Financial Statements Comparison: Varex Imaging vs Abbott Laboratories
Financial Metrics
Loading Financial Charts...
Revenue
EBITDA
Operating Margin
Free Cash Flow
Long Term Debt
Profit Margin
Current Ratio
Operating Cash Flow
Income Statement (MRQ)
| Metric (MRQ) | VREX | ABT |
|---|---|---|
| Revenue/Sales | $212.90M | $10.36B |
| Cost of Goods Sold | $136.20M | $4.47B |
| Gross Profit | $76.70M | $5.89B |
| Research & Development | $22.00M | $716.00M |
| Operating Income (EBIT) | $22.10M | $1.69B |
| EBITDA | $26.80M | $2.66B |
| Pre-Tax Income | $10.80M | $1.78B |
| Income Tax | $3.70M | $453.00M |
| Net Income (Profit) | $7.10M | $1.33B |
Balance Sheet & Liquidity Metrics (MRQ)
| Metric (MRQ) | VREX | ABT |
|---|---|---|
| Cash & Equivalents | $205.10M | $6.53B |
| Total Current Assets | $683.80M | $23.15B |
| Total Current Liabilities | $168.80M | $13.00B |
| Long-Term Debt | $585.40M | $12.74B |
| Total Shareholders Equity | $563.90M | $49.06B |
| Retained Earnings | $77.00M | $47.72B |
| Property, Plant & Equipment | $177.60M | N/A |
Cash Flow Statement Comparison (MRQ)
| Metric (MRQ) | VREX | ABT |
|---|---|---|
| Operating Cash Flow | $11.60M | $1.42B |
| Capital Expenditures | $-6.80M | $-484.00M |
| Free Cash Flow | $9.80M | $933.00M |
| Debt Repayment | $-400,000 | $-1.00B |
| Common Stock Repurchase | N/A | $-280.00M |
Short Interest & Institutional Ownership Analysis
| Metric | VREX | ABT |
|---|---|---|
| Shares Short | 1.22M | 17.11M |
| Short Ratio | 2.44 | 2.18 |
| Short % of Float | 0.03% | 0.01% |
| Average Daily Volume (10 Day) | 367,070 | 4,507,400 |
| Average Daily Volume (90 Day) | 477,890 | 5,725,327 |
| Shares Outstanding | 41.09M | 1.73B |
| Float Shares | 40.96M | 1.73B |
| % Held by Insiders | 0.02% | 0.01% |
| % Held by Institutions | 0.96% | 0.81% |
Dividend Analysis & Yield Comparison: Varex Imaging vs Abbott Laboratories
| Metric | VREX | ABT |
|---|---|---|
| Last 12-Month Dividend | N/A | $1.69 |
| Last 12-Month Dividend Yield | N/A | 1.28% |
| 3-Year Avg Annual Dividend | N/A | $1.92 |
| 3-Year Avg Dividend Yield | N/A | 0.49% |
| 3-Year Total Dividends | N/A | $5.77 |
| Ex-Dividend Date | N/A | Jan 15, 2025 |